ProPhase Labs to seek shareholder approval to increase authorized shares to 1 billion for crypto treasury strategy

ProPhase Labs, Inc.

Special Meeting of Shareholders on August 29, 2025 to vote on increasing authorized shares to 1 billion.
Board unanimously recommends approval to attract high-value crypto treasury transactions and market participants.
Company aims to collect approximately $50 million from COVID accounts receivables to fund potential crypto strategy.
Continuing development of BE-Smart esophageal cancer test and exploring strategic alternatives for Nebula Genomics, including a possible sale.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.